162 Investigation of TLR7/8 and 9 Agonists and CD40-ligand Costimulation on EBV Transformation of B Cells of Chronic Lymphocytic Leukemia
Vahid Younesi(Tehran University of Medical Sciences), Fazel Shokri(Academic Center for Education, Culture and Research), Seyed Mohsen Razavi(Firoozgar General Hospital), Haleh Nikzamir(Kagoshima University), Mohammad Hojjat‐Farsangi(Karolinska University Hospital)
Cited by 0
Related Papers
Nanoparticles and targeted drug delivery in cancer therapy
|Immunology Letters|2017|507
The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer
|Biomedicine & Pharmacotherapy|2018|312
Small-Molecule Inhibitors of the Receptor Tyrosine Kinases: Promising Tools for Targeted Cancer Therapies
|International Journal of Molecular Sciences|2014|202
CDK1 in Breast Cancer: Implications for Theranostic Potential
|Anti-Cancer Agents in Medicinal Chemistry|2020|169
Adenosine and adenosine receptors in the immunopathogenesis and treatment of cancer
|Journal of Cellular Physiology|2017|150